Coelho Rogerio Vivaldi

Companies

• ViatrisBoard member Jun 4, 2024 to now¹
• Crinetics PharmaceuticalsBoard member Jan 10, 2022 to now²
• Sigilon Therapeutics, Inc.Board member Dec 3, 2020 to Aug 11, 2023³
• Sigilon Therapeutics, Inc.Chief executive officer Dec 3, 2020 to Aug 11, 2023³
• Sigilon Therapeutics, Inc.President Dec 3, 2020 to Aug 11, 2023³
• Minerva Neurosciences (United States)Board member Jun 30, 2014 to Sep 26, 2014⁴
• Minerva Neurosciences (United States)Chief executive officer Jun 30, 2014 to Sep 26, 2014⁴
• Minerva Neurosciences (United States)President Jun 30, 2014 to Sep 26, 2014⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Viatris VTRS46,526 shares⁵$867.2K at $18.64Mar 6, 2026
• Crinetics Pharmaceuticals0 shares⁶Sep 1, 2026
• STSigilon Therapeutics, Inc.0 shares⁷Aug 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals⁶
• Sep 1, 2026Returned to company 13,300 shares at $85.00 of Crinetics Pharmaceuticals⁶
• Jul 2, 2026Sold 3,000 shares at $40.00 of Crinetics Pharmaceuticals⁸
• Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals⁹
• Mar 12, 2026Sold 523 shares at $36.77 of Crinetics Pharmaceuticals¹⁰
• Mar 12, 2026Sold 4,477 shares at $36.08 of Crinetics Pharmaceuticals¹⁰
• Mar 6, 2026Exercised options 1,175 shares of Viatris⁵
• Mar 6, 2026Exercised options 23,660 shares of Viatris⁵
• Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals¹¹
• Mar 4, 2025Exercised options 424 shares of Viatris¹²
• Mar 4, 2025Exercised options 21,267 shares of Viatris¹²
• Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals¹³
• Aug 11, 2023Returned to company 12,169 shares of Sigilon Therapeutics, Inc.⁷
• Jul 21, 2023Exercised options 5,528 shares at $19.24 of Sigilon Therapeutics, Inc.¹⁴
• Jun 16, 2023Granted 6,000 shares of Crinetics Pharmaceuticals¹⁵
• Jun 8, 2023Bought 5,000 shares at $22.06 of Crinetics Pharmaceuticals¹⁶
• Nov 4, 2021Granted 50,000 shares of Sigilon Therapeutics, Inc.¹⁷